CoreCivic Inc (CXW)
NYSE:CXW
Want to see CXW full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.33Last Year’s EPS
0.35Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlighted strong sequential and year-over-year financial performance (notably adjusted EBITDA +36%, adjusted EPS +74%, and meaningful federal/ICE-driven revenue growth), successful activation of idled facilities, a strategic acquisition (Clinical Solutions) that materially expands recurring revenue and adjacencies, and continued shareholder-friendly capital deployment (buybacks). Offsetting risks include short-term ICE population volatility that pressures Q2 results, some decline in Marshals revenue, dependence on government funding and policy decisions (including potential ICE asset ownership or warehouse strategies), and modest near-term leverage and short-term borrowings. On balance, the operational and financial upside — including raised full-year guidance, accretive acquisition, and strong organic activations — outweigh the transitory policy and population headwinds.Company Guidance
Strong financial outperformance
Adjusted EBITDA of $110.1M in Q1 2026, up 36% YoY (from $81.0M); adjusted EPS (ex‑M&A) $0.40 vs $0.23 prior, a 74% increase; normalized FFO per share $0.65 vs $0.45 prior, up 44%; GAAP EPS $0.38. Results beat consensus by $0.12 per share (EPS) and $13.3M (adjusted EBITDA).
Material federal revenue growth driven by ICE
Federal revenue grew 48% YoY, with ICE revenue increasing $128.1M (a 96.2% increase). ICE populations in CoreCivic care rose ~4,500 individuals (≈45% increase from beginning of 2025 to Mar 31, 2026). CoreCivic managed ~24% of total ICE populations at quarter end.
Meaningful organic capacity activations
Five idle facilities were activated; revenue from four activated facilities totaled $100.8M in Q1 (annualized ≈93% of expected stabilized revenue). California City and Diamondback had 1,817 and 735 individuals respectively as of Mar 31. Midwest Regional Reception Center reactivation approved and expected to add $0.05–$0.06 incremental EPS for remainder of 2026.
Strategic acquisition expands addressable market (Clinical Solutions Pharmacy)
Acquired Clinical Solutions Pharmacy for ~$148M (paid with cash and revolver borrowings). CSP serves over 600 correctional facilities across 28 states, fills ~60,000 prescriptions/day, 50% of shipments fully automated, no single customer >15% revenue. CSP expected to generate $215M–$230M revenue in 2026 and contribute $0.03–$0.05 EPS (net of acquisition financing).
Improved 2026 guidance and cash-flow outlook
Raised full-year guidance: adjusted diluted EPS $1.53–$1.63 (from $1.49–$1.59 prior); adjusted EBITDA $453.8M–$461.8M (up from $437M–$445M); FFO per share and normalized FFO per share ranges increased slightly. AFFO guidance of $250.4M–$264.9M supports capital deployment plans.
Continued shareholder capital returns
Repurchased 2.3M shares in Q1 for $44.7M; cumulative repurchases since 2022 of 28.1M shares for $444.2M (avg $15.82/share), with $255.8M remaining authorization. Management prioritizes continued buybacks where accretive.
Solid liquidity and balance-sheet management
Cash of $209.7M and $131.3M revolver availability (revolver balance $425M outstanding) for total liquidity ~$341M as of Mar 31, 2026. Net debt to adjusted EBITDA of 2.8x (TTM). Executed $100M 364‑day term loan post-quarter to replenish revolver borrowings.
Stable/improving operating margins
Combined operating margin for Safety & Community facilities was 24% in Q1 2026 vs 23.6% prior year; excluding employee retention credits, operating margins were ~23% in both periods, indicating stable operational performance despite capacity activations.
CXW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CXW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $21.17 | $21.82 | +3.07% |
Feb 11, 2026 | $18.50 | $17.86 | -3.46% |
Nov 05, 2025 | $18.64 | $16.79 | -9.92% |
Aug 06, 2025 | $19.60 | $20.00 | +2.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CoreCivic Inc (CXW) report earnings?
CoreCivic Inc (CXW) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is CoreCivic Inc (CXW) earnings time?
CoreCivic Inc (CXW) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CXW EPS forecast?
CXW EPS forecast for the fiscal quarter 2026 (Q2) is 0.33.